Radiopharm Theranostics Overview
- Year Founded
-
2021
- Status
-
Public
- Employees
-
14
- Stock Symbol
-
RAD
- Investments
-
2
Radiopharm Theranostics General Information
Description
Radiopharm Theranostics Ltd is a clinical-stage radiotherapeutics company focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. It develops and commercializes radiopharmaceutical platforms for therapeutic and diagnostic applications in precision oncology. The Company develops targeted and scientifically validated radiopharmaceutical technologies in pre-clinical and clinical stages. It has one reportable segment, being the research, development, and commercialization of health technologies. The Company operates in Australia and the United States, with maximum revenue from the United States.
Contact Information
Website
www.radiopharmtheranostics.comCorporate Office
- Company Secretary, C - The CFO Solution Level 3
- 62 Lygon Street
- Carlton, New South Wales 3053
- Australia
Corporate Office
- Company Secretary, C - The CFO Solution Level 3
- 62 Lygon Street
- Carlton, New South Wales 3053
- Australia
Radiopharm Theranostics Timeline
Radiopharm Theranostics Stock Performance
As of 20-Nov-2026, Radiopharm Theranostics’s current market cap is $12.5M with 4.71B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.5M | 4.71B | 7.29M | -$0.01 |
Radiopharm Theranostics Financials Summary
As of 30-Jun-2026, Radiopharm Theranostics has a trailing 12-month revenue of $1.88M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 31,654 | 31,654 | 8,957 | 10,447 |
| Revenue | 1,875 | 1,875 | 2,351 | 196 |
| EBITDA | (38,894) | (38,894) | (25,269) | (30,967) |
| Net Income | (38,580) | (38,580) | (24,808) | (31,423) |
| Total Assets | 41,383 | 41,383 | 56,489 | 48,149 |
| Total Debt | 17,737 | 17,737 | 20,966 | 20,768 |
Radiopharm Theranostics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Radiopharm Theranostics Comparisons
Industry
Financing
Details
Radiopharm Theranostics Competitors (2)
One of Radiopharm Theranostics’s 2 competitors is AdvanCell, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AdvanCell | Venture Capital-Backed | Boston, MA | ||||
| Clarity Pharmaceuticals | Formerly VC-backed | Eveleigh, Australia |
Radiopharm Theranostics Patents
Radiopharm Theranostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026905961-A0 | Dendrimer | Pending | 01-Jul-2026 |
Radiopharm Theranostics Signals
Radiopharm Theranostics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Radiopharm Theranostics Investments & Acquisitions (2)
Radiopharm Theranostics’s most recent deal was a Merger/Acquisition with Pharma15 for . The deal was made on 03-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pharma15 | 03-Mar-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| Radiopharm Ventures | 13-Sep-2022 | Joint Venture | Drug Discovery |
Radiopharm Theranostics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
Radiopharm Theranostics FAQs
-
When was Radiopharm Theranostics founded?
Radiopharm Theranostics was founded in 2021.
-
Where is Radiopharm Theranostics headquartered?
Radiopharm Theranostics is headquartered in Carlton, Australia.
-
What is the size of Radiopharm Theranostics?
Radiopharm Theranostics has 14 total employees.
-
What industry is Radiopharm Theranostics in?
Radiopharm Theranostics’s primary industry is Drug Discovery.
-
Is Radiopharm Theranostics a private or public company?
Radiopharm Theranostics is a Public company.
-
What is Radiopharm Theranostics’s stock symbol?
The ticker symbol for Radiopharm Theranostics is RAD.
-
What is the current market cap of Radiopharm Theranostics?
The current market capitalization of Radiopharm Theranostics is $12.5M.
-
What is Radiopharm Theranostics’s current revenue?
The trailing twelve month revenue for Radiopharm Theranostics is $1.88M.
-
Who are Radiopharm Theranostics’s competitors?
AdvanCell and Clarity Pharmaceuticals are competitors of Radiopharm Theranostics.
-
What is Radiopharm Theranostics’s annual earnings per share (EPS)?
Radiopharm Theranostics’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process